Zobrazeno 1 - 3
of 3
pro vyhledávání: '"Shelly O'Laughlin"'
Autor:
Molly C Schroeder, Scott Kruchowski, David H. Spencer, Shelly O'Laughlin, Matthew Bohannon, Eric J. Duncavage, R. Wilson
Publikováno v:
Cancer Genetics. 244:4-5
Autor:
Jeffery M. Klco, Benjamin J. Ainscough, Katie M. Campbell, Vincent Magrini, Malachi Griffith, Jason Walker, Nicholas C. Spies, John F. DiPersio, Peter Westervelt, David E. Larson, Sharon Heath, Jin Zhang, Catrina Fronick, Jasreet Hundal, Elaine R. Mardis, Shelly O'Laughlin, Timothy J. Ley, Sean McGrath, Christopher G. Maher, Christopher A. Miller, Kilannin Krysiak, Robert Lesurf, Timothy A. Graubert, Matthew J. Christopher, Robert S. Fulton, Daniel C. Link, Jacqueline E. Payton, James M. Eldred, Alex H. Wagner, Zachary L. Skidmore, Tamara Lamprecht, Avinash Ramu, Rick K. Wilson, Scott M. Smith, Matthew J. Walter, Obi L. Griffith, Shashikant Kulkarni
Publikováno v:
Experimental Hematology. 44:603-613
The genomic events responsible for the pathogenesis of relapsed adult B-lymphoblastic leukemia (B-ALL) are not yet clear. We performed integrative analysis of whole-genome, whole-exome, custom capture, whole-transcriptome (RNA-seq), and locus-specifi
Autor:
Jeffery M. Klco, Robert S. Fulton, Christopher B Cole, Angela M. Verdoni, Amanda Smith, Christopher A. Miller, Shelly O'Laughlin, Shamika Ketkar, Catrina Fronick, Nichole M. Helton, Timothy J. Ley, Gue Su Chang, David A. Russler-Germain, Allegra A. Petti, Celia V. Bangert, Mindy Guo
The gene that encodes de novo DNA methyltransferase 3A (DNMT3A) is frequently mutated in acute myeloid leukemia genomes. Point mutations at position R882 have been shown to cause a dominant negative loss of DNMT3A methylation activity, but 15% of DNM
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::6eeaaa508205355ed1e496380e9c9123
https://europepmc.org/articles/PMC5617681/
https://europepmc.org/articles/PMC5617681/